Neuros Medical

The Altius® Direct Electrical Nerve Stimulation System is the first device FDA-approved to specifically address chronic post-amputation pain. Altius is indicated as an aid in the management of chronic intractable phantom and residual lower limb post-amputation pain in adult amputees. It is a patient-controlled, on-demand system that uses Neuros’ patented technology to address the underlying cause of post-amputation pain by inhibiting pain signal transmission from damaged peripheral nerves to the central nervous system.​

There are nearly two million amputees in the U.S., with 185,000 new amputations occurring every year. Post-amputation pain includes both phantom limb pain and residual limb pain and impacts nearly one million Americans, representing a significant unmet medical need, as existing treatment options are limited and consist primarily of opioids and gabapentinoids. Neuros is a privately held company and the maker of the Altius® Direct Electrical Nerve Stimulation System designed for the treatment of chronic post-amputation pain. Our mission is to reduce pain and restore life for people suffering with post-amputation pain. We are a passionate team guided by our core values, and committed to our patients and the healthcare professionals who care for them.